| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Clinical Investigations |
1 Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
2 Department of Radiology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
3 Department of Oncology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
The purpose of the study was to assess the role of 18F-FDG PET/CT in the assessment of secondary malignant involvement of the spinal column. Methods: In 51 patients, 242 lesions at the spinal region detected on 18F-FDG PET/CT were interpreted separately on PET, CT, and fused PET/CT images, including differentiation between benign and malignant lesions and the level in the vertebral column. CT evaluation also included the type of bony lesion (osteolytic, osteoblastic, or mixed) and accompanying soft-tissue abnormalities; for example, epidural masses and tumor involvement of the neural foramina. Results: Of the 242 lesions detected on PET/CT, PET alone identified 220 lesions and CT alone identified 159; 217 (90%) were malignant and 25 benign. 18F-FDG PET alone detected significantly more malignant lesions than did CT alone (96% vs. 68%, respectively, P < 0.001). The specificity was 56% for both PET alone and CT alone. PET alone was incorrect in determining the level of abnormality within the vertebral column in 33 (15%) lesions and in determining the part of the vertebra involved in 40 (18%) lesions. In 17 (33%) patients, either epidural extension of tumor (n = 7 lesions), neural foramen involvement of tumor (n = 7 lesions), or a combination of both (n = 11 lesions) was detected. On a patient-based analysis, the sensitivity of PET and of PET/CT for the detection of spinal metastasis was 98% and 74%, respectively (P < 0.01). Conclusion: 18F-FDG PET/CT has better specificity for detection of malignant involvement of the spine than does 18F-FDG PET. It allows for precise localization of lesions and identifies accompanying soft-tissue involvement, which is of potential neurologic significance.
Key Words: PET/CT • spine • 18F-FDG • epidural
This article has been cited by other articles:
|
|
 |
|
  Y. Du, I. Cullum, T. M. Illidge, and P. J. Ell Fusion of Metabolic Function and Morphology: Sequential [18F]Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Studies Yield New Insights Into the Natural History of Bone Metastases in Breast Cancer J. Clin. Oncol., August 10, 2007; 25(23): 3440 - 3447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Basu, B. A. Siegel, D. J. McDonald, and B. Nussenbaum Detection of Occult Bone Metastases From Head and Neck Squamous Cell Carcinoma: Impact of Positron Emission Tomography Computed Tomography With Fluorodeoxyglucose F 18 Arch Otolaryngol Head Neck Surg, August 1, 2007; 133(8): 801 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Taira, R. J. Herfkens, S. S. Gambhir, and A. Quon Detection of Bone Metastases: Assessment of Integrated FDG PET/CT Imaging Radiology, April 1, 2007; 243(1): 204 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. O'Connor, J. Yao, and R. M. Summers Lytic Metastases in Thoracolumbar Spine: Computer-aided Detection at CT--Preliminary Study Radiology, March 1, 2007; 242(3): 811 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Rosen, L. Fayad, and R. L. Wahl Increased 18F-FDG Uptake in Degenerative Disease of the Spine: Characterization with 18F-FDG PET/CT J. Nucl. Med., August 1, 2006; 47(8): 1274 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Even-Sapir Imaging of Malignant Bone Involvement by Morphologic, Scintigraphic, and Hybrid Modalities J. Nucl. Med., August 1, 2005; 46(8): 1356 - 1367. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
